APA (7th ed.) Citation

A, D. C., F, B., V, V., B, V., A, J., S, H., . . . A, B. (2026). Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 31(2), . https://doi.org/10.2807/1560-7917.ES.2026.31.2.2500992

Chicago Style (17th ed.) Citation

A, De Clercq, et al. "Interim Vaccine Effectiveness Against Influenza Virus Among Outpatients, France, October 2025 to January 2026." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 31, no. 2 (2026). https://doi.org/10.2807/1560-7917.ES.2026.31.2.2500992.

MLA (9th ed.) Citation

A, De Clercq, et al. "Interim Vaccine Effectiveness Against Influenza Virus Among Outpatients, France, October 2025 to January 2026." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 31, no. 2, 2026, https://doi.org/10.2807/1560-7917.ES.2026.31.2.2500992.